Public/private partnership expands access to comprehensive genomic profiling to improve patient care and advance drug discovery
At ESHG in Vienna, Illumina representatives engaged with an impressive group of geneticists and entrepreneurs
How artificial intelligence and automation are enabling precision medicine to become the standard of care
At ASCO 2022, an oncology panel discusses the benefits and practices of comprehensive genomic profiling
Illumina’s global program aims to inspire the next generation of genomic leaders
| Date | Publication | Title |
|---|---|---|
| Jun 16, 2022 | Business Weekly | Illumina toasts Accelerator success in Cambridge |
| May 26, 2022 | Channel News Asia | DNA of 100,000 Singaporeans to be sequenced, analysed to improve population health |
| May 24, 2022 | Genome Web | Illumina Adds CDx Indication to European TruSight Oncology Test for NTRK Gene Fusion Detection |
| Apr 19, 2022 | Inside Precision Medicine | Growing Pains |
| Apr 12, 2022 | Hälsa | Pilot Projects Have Begun With a Broad Analysis of the Genome in the Fight Against Cancer Tumors |
At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.
